Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Longitudinal analysis of the immune response in patients with COVID-19 identifies a myeloid signature associated with severe disease.

Original publication

DOI

10.1126/sciimmunol.abd6197

Type

Journal article

Journal

Science Immunology

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

18/09/2020

Volume

5